Ceftriaxone controlled release - scPharmaceuticals/Sensile Medical

Drug Profile

Ceftriaxone controlled release - scPharmaceuticals/Sensile Medical

Alternative Names: Cephalosporin antibiotic micropump patch - scPharmaceuticals

Latest Information Update: 28 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator scPharmaceuticals
  • Class Antibacterials; Cephalosporins; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Bacterial infections

Most Recent Events

  • 26 Oct 2016 Pharmacokinetics data from a phase II/III trial in Bacterial infections (In volunteers) released by scPharmaceuticals (SC)
  • 02 Mar 2016 Ceftriaxone controlled release meets primary endpoints in its phase II/III trial inn Bacterial infections
  • 13 Nov 2015 scPharmaceuticals announces intention to submit NDA to the US FDA in 2H 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top